Total Payments
$20,568
2024 Payments
$3,231
Companies
29
Transactions
550
Medicare Patients
14,828
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$19,985 (97.2%)
Consulting$500.00 (2.4%)
Education$82.17 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,985 | 547 | 97.2% |
| Consulting Fee | $500.00 | 1 | 2.4% |
| Education | $82.17 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $6,500 | 76 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,874 | 14 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,479 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,458 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,112 | 50 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $899.39 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $743.39 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $730.69 | 24 | $0 (2024) |
| Amgen Inc. | $681.48 | 30 | $0 (2024) |
| Boston Scientific Corporation | $674.42 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,231 | 115 | Abbott Laboratories ($817.28) |
| 2023 | $3,485 | 135 | Abbott Laboratories ($789.03) |
| 2022 | $3,891 | 123 | Abbott Laboratories ($1,091) |
| 2021 | $4,078 | 121 | Abbott Laboratories ($1,112) |
| 2020 | $897.84 | 11 | Abbott Laboratories ($640.64) |
| 2019 | $1,432 | 12 | Abbott Laboratories ($783.81) |
| 2018 | $1,813 | 16 | Medtronic Vascular, Inc. ($581.28) |
| 2017 | $1,741 | 17 | Medtronic Vascular, Inc. ($859.66) |
All Payment Transactions
550 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $117.32 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/31/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $70.39 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.76 | General |
| Category: Cardiovascular | ||||||
| 10/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.76 | General |
| Category: Cardiovascular | ||||||
| 10/11/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 4,013 | 6,071 | $1.9M | $463,487 |
| 2022 | 24 | 3,988 | 6,160 | $2.0M | $493,528 |
| 2021 | 20 | 3,445 | 5,276 | $1.6M | $427,788 |
| 2020 | 22 | 3,382 | 4,778 | $1.3M | $282,415 |
Total Patients
14,828
Total Services
22,285
Medicare Billing
$1.7M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 827 | 1,483 | $655,486 | $168,029 | 25.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 566 | 577 | $399,284 | $91,068 | 22.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 335 | 335 | $230,815 | $58,120 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 381 | 467 | $146,171 | $36,203 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 148 | 368 | $99,360 | $27,024 | 27.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,091 | 1,977 | $102,804 | $24,967 | 24.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 62 | 101 | $27,922 | $7,259 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $26,634 | $6,503 | 24.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 115 | 115 | $28,290 | $6,412 | 22.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 80 | 81 | $20,979 | $5,272 | 25.1% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 36 | 57 | $19,551 | $5,115 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $19,306 | $4,838 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 82 | $16,236 | $4,285 | 26.4% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 40 | 40 | $17,040 | $3,680 | 21.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $8,046 | $2,203 | 27.4% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 22 | 35 | $8,195 | $2,183 | 26.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 102 | $8,364 | $2,037 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 22 | $7,304 | $2,000 | 27.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 42 | $7,266 | $1,982 | 27.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 15 | 16 | $5,904 | $1,520 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 24 | $5,424 | $1,481 | 27.3% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 12 | 13 | $3,692 | $892.04 | 24.2% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 21 | 21 | $1,680 | $414.01 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 853 | 1,587 | $707,802 | $182,141 | 25.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 535 | 544 | $388,960 | $91,008 | 23.4% |
About Dr. Michael Mannino, M.D
Dr. Michael Mannino, M.D is a Cardiovascular Disease healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598761660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mannino, M.D has received a total of $20,568 in payments from pharmaceutical and medical device companies, with $3,231 received in 2024. These payments were reported across 550 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($19,985).
As a Medicare-enrolled provider, Mannino has provided services to 14,828 Medicare beneficiaries, totaling 22,285 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Manhasset, NY
- Active Since 06/23/2005
- Last Updated 02/11/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1598761660
Products in Payments
- Resolute (Device) $1,528
- XARELTO (Drug) $1,458
- Quadra Assura CRT Defibrillator (Device) $1,399
- AVEIR (Device) $1,204
- ENTRESTO (Drug) $1,144
- FARXIGA (Drug) $970.86
- ELIQUIS (Drug) $825.76
- VERQUVO (Drug) $743.39
- JARDIANCE (Drug) $713.89
- Repatha (Biological) $681.48
- Optimizer Smart System (Device) $625.00
- ASSURITY (Device) $585.36
- NEXLETOL (Drug) $499.99
- Merlin Connectivity and Remote (Device) $443.69
- Pacemakers (Device) $429.20
- Confirm Rx (Device) $395.52
- Verquvo (Drug) $378.13
- WATCHMAN (Device) $337.81
- LEQVIO (Drug) $335.77
- CardioMEMS HF System (Device) $303.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Manhasset
Bruce Rutkin, Md, MD
Cardiovascular Disease — Payments: $328,717
Cardiovascular Disease $328,717
Mitchell Weinberg, Md, MD
Cardiovascular Disease — Payments: $163,984
Cardiovascular Disease $163,984
Dr. Perwaiz Meraj, M.d, M.D
Cardiovascular Disease — Payments: $121,905
Cardiovascular Disease $121,905
Dr. Benjamin Hirsh, M.d, M.D
Cardiovascular Disease — Payments: $50,588
Cardiovascular Disease $50,588
Dr. Andrea Mignatti, M.d, M.D
Cardiovascular Disease — Payments: $24,976
Cardiovascular Disease $24,976
Stuart Beldner, Md, MD
Cardiovascular Disease — Payments: $19,150
Cardiovascular Disease $19,150